Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Health benefits gained from using new-generation weight-loss drugs Ozempic, Wegovy and Maunjaro are lost, and weight is ...

A man and a woman have been arrested after two plain-clothes police officers were "asked if they were looking to buy drugs" ...

46 new molecular entities cleared the agency’s hurdles last year, 4 fewer than in 2024 ...

In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...

The settlement covers anyone who has been or is currently enrolled as a CAF member starting from April 17, 1985, up to and ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

In Nation Healthcare Security Administration’s (NHSA’s) announcement for the 2025 NRDL, the government’s support for ...

The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients and ...

Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...

WASHINGTON – President Donald Trump signed an executive order Dec. 18 to federally classify marijuana as a less dangerous substance, the biggest change for the drug since 1970 and an opportunity for ...